Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.
Publication
, Conference
Khasraw, M; Mukaro, VR; West, L; White, K; Rippy, E; Brandt, C; Tobler, R; Murphy, CC; Collins, IM; Baron-Hay, SE; Ashley, DM; Patil, S
Published in: Journal of Clinical Oncology
May 20, 2016
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2016
Volume
34
Issue
15_suppl
Start / End Page
e12515 / e12515
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., Mukaro, V. R., West, L., White, K., Rippy, E., Brandt, C., … Patil, S. (2016). Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. In Journal of Clinical Oncology (Vol. 34, pp. e12515–e12515). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e12515
Khasraw, Mustafa, Violet Rudo Mukaro, Linda West, Karen White, Elisabeth Rippy, Conrad Brandt, Robert Tobler, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.” In Journal of Clinical Oncology, 34:e12515–e12515. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e12515.
Khasraw M, Mukaro VR, West L, White K, Rippy E, Brandt C, et al. Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e12515–e12515.
Khasraw, Mustafa, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e12515–e12515. Crossref, doi:10.1200/jco.2016.34.15_suppl.e12515.
Khasraw M, Mukaro VR, West L, White K, Rippy E, Brandt C, Tobler R, Murphy CC, Collins IM, Baron-Hay SE, Ashley DM, Patil S. Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e12515–e12515.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2016
Volume
34
Issue
15_suppl
Start / End Page
e12515 / e12515
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences